Emily Lau, MD

Dr. Emily Lau is a women’s cardiovascular health specialist and investigator at Massachusetts General Hospital. Dr. Lau directs the Cardiometabolic Hormones and Health Clinic in the Corrigan Women’s Heart Health program. Dr. Lau’s laboratory focuses on understanding how biologic sex differences and female-specific cardiovascular risk factors contribute to the pathogenesis of cardiovascular disease uniquely in women. She leads a clinical-translational research program that applies multi-dimensional molecular profiling (multi-omics), imaging, exercise physiology, and data science to large scale cohorts, electronic health record data, and patient-oriented studies to advance mechanistic understanding of women’s cardiovascular health and disease. Several active areas of investigation include: (1) identifying and characterizing biologic sex differences in cardiovascular disease susceptibility, pathogenesis, and response to therapy, (2) investigating immunometabolic and hormonal mechanisms of cardiovascular disease in women, and (3) identifying novel digital biomarkers to improve cardiovascular disease risk assessment in women. Dr. Lau’s research is supported by the NIH/NHLBI, American Heart Association, and the MGH SPARK Award.

Dr. Lau received her undergraduate degree in Human Biology at Brown University, MD from the Warren Alpert Medical School of Brown University, and MPH at the Harvard T.H. Chan School of Public Health. She trained in Internal Medicine at the Brigham and Women’s Hospital, where she also served as Chief Medical Resident. She completed fellowships in Cardiovascular Disease and Advanced Echocardiography at the Massachusetts General Hospital. Dr. Lau is the recipient of the Roman W. DeSanctis Clinical Scholar Award, the Anne Klibanski Visiting Scholars Award, and the Sheila Balson Endowed Cardiac Scholar.

Research Areas
Cardiac Physiology and Disease
Genomics